|
Vaccine Detail
Recombinant Adenovirus-LacZ Vaccine |
Vaccine Information |
- Vaccine Name: Recombinant Adenovirus-LacZ Vaccine
- Target Pathogen: Cancer
- Target Disease: Cancer
- Vaccine Ontology ID: VO_0007005
- Type: Recombinant vector vaccine
- Status: Clinical trial
- Host Species for Licensed Use: Human
- Host Species as Laboratory Animal Model: Human
- lacZ
gene engineering:
- Type: Recombinant protein preparation
- Description:
- Detailed Gene Information: Click Here.
- Preparation: An adenovirus is used as a vector encoding LacZ (Zhai et al., 2011).
- Description: This is for Brain Cancer. Please refer to (Zhai et al., 2011; NCIT_C29786).
|
Host Response |
|
References |
NCIT_C29786: [https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29786]
Zhai et al., 2011: Zhai SQ, Guo W, Hu YY, Yu N, Chen Q, Wang JZ, Fan M, Yang WY. Protective effects of brain-derived neurotrophic factor on the noise-damaged cochlear spiral ganglion. The Journal of laryngology and otology. 2011; 125(5); 449-454. [PubMed: 21078216].
|
|